A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infe...
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation surrounding tuberculosis is limited due to its complex nature and the fact that it affects a wide range of individuals differently. The disease can manifest variably, and many cases remain unrecognized, particularly in less severe forms. Additionally, the focus on treatment and control in public health has overshadowed the need for comprehensive clinical studies, especially in rare manifestations.
To navigate your tuberculosis diagnosis, consider consulting an infectious disease specialist with experience in managing TB. They can provide tailored treatment options and monitoring strategies. Additionally, you might explore participation in clinical trials, which could offer access to new therapies. For more information, visit ClinicalTrials.gov for ongoing studies. While there are currently no specific patient organizations identified for tuberculosis, resources like the CDC (cdc.gov/tb) offer valuable information and support.
Currently, there are several orphan drugs designated for tuberculosis, including bedaquiline, which is FDA-approved, and others such as heat-killed Mycobacterium with immunomodulator and tubimod, which are still in development. There are 293 active clinical trials investigating various aspects of tuberculosis treatment and management. For more details, you can explore ongoing studies at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=tuberculosis.
Actionable guidance for navigating care for tuberculosis
To navigate your tuberculosis diagnosis, consider consulting an infectious disease specialist with experience in managing TB. They can provide tailored treatment options and monitoring strategies. Additionally, you might explore participation in clinical trials, which could offer access to new therapies. For more information, visit ClinicalTrials.gov for ongoing studies. While there are currently no specific patient organizations identified for tuberculosis, resources like the CDC (cdc.gov/tb) offer valuable information and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation surrounding tuberculosis is limited due to its complex nature and the fact that it affects a wide range of individuals differently. The disease can manifest variably, and many cases remain unrecognized, particularly in less severe forms. Additionally, the focus on treatment and control in public health has overshadowed the need for comprehensive clinical studies, especially in rare manifestations.
To navigate your tuberculosis diagnosis, consider consulting an infectious disease specialist with experience in managing TB. They can provide tailored treatment options and monitoring strategies. Additionally, you might explore participation in clinical trials, which could offer access to new therapies. For more information, visit ClinicalTrials.gov for ongoing studies. While there are currently no specific patient organizations identified for tuberculosis, resources like the CDC (cdc.gov/tb) offer valuable information and support.
Currently, there are several orphan drugs designated for tuberculosis, including bedaquiline, which is FDA-approved, and others such as heat-killed Mycobacterium with immunomodulator and tubimod, which are still in development. There are 293 active clinical trials investigating various aspects of tuberculosis treatment and management. For more details, you can explore ongoing studies at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=tuberculosis.
Actionable guidance for navigating care for tuberculosis
To navigate your tuberculosis diagnosis, consider consulting an infectious disease specialist with experience in managing TB. They can provide tailored treatment options and monitoring strategies. Additionally, you might explore participation in clinical trials, which could offer access to new therapies. For more information, visit ClinicalTrials.gov for ongoing studies. While there are currently no specific patient organizations identified for tuberculosis, resources like the CDC (cdc.gov/tb) offer valuable information and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation surrounding tuberculosis is limited due to its complex nature and the fact that it affects a wide range of individuals differently. The disease can manifest variably, and many cases remain unrecognized, particularly in less severe forms. Additionally, the focus on treatment and control in public health has overshadowed the need for comprehensive clinical studies, especially in rare manifestations.
To navigate your tuberculosis diagnosis, consider consulting an infectious disease specialist with experience in managing TB. They can provide tailored treatment options and monitoring strategies. Additionally, you might explore participation in clinical trials, which could offer access to new therapies. For more information, visit ClinicalTrials.gov for ongoing studies. While there are currently no specific patient organizations identified for tuberculosis, resources like the CDC (cdc.gov/tb) offer valuable information and support.
Currently, there are several orphan drugs designated for tuberculosis, including bedaquiline, which is FDA-approved, and others such as heat-killed Mycobacterium with immunomodulator and tubimod, which are still in development. There are 293 active clinical trials investigating various aspects of tuberculosis treatment and management. For more details, you can explore ongoing studies at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=tuberculosis.
Actionable guidance for navigating care for tuberculosis
To navigate your tuberculosis diagnosis, consider consulting an infectious disease specialist with experience in managing TB. They can provide tailored treatment options and monitoring strategies. Additionally, you might explore participation in clinical trials, which could offer access to new therapies. For more information, visit ClinicalTrials.gov for ongoing studies. While there are currently no specific patient organizations identified for tuberculosis, resources like the CDC (cdc.gov/tb) offer valuable information and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning tuberculosis
Updated Jan 29, 2026
The CDC highlights the need for improved tuberculosis testing protocols following a school-based exposure incident in Lake County, Illinois. This report emphasizes the importance of addressing violence exposure in childhood as a factor in health outcomes.
The CDC reports on the performance of the CureTB program from 2016 to 2023, focusing on continuity of care for tuberculosis patients relocating internationally. This evaluation highlights the program's impact on patient management and health outcomes.
The CDC provides an update on a tuberculosis case involving an international traveler, emphasizing the importance of monitoring and reporting such cases. This highlights ongoing public health efforts to manage and control tuberculosis outbreaks.
The CDC updates on its investigation into individuals potentially exposed to a patient with extensively drug-resistant tuberculosis (TB). This telebriefing highlights ongoing efforts to manage and contain the spread of this serious public health threat.
The CDC is conducting an investigation into individuals potentially exposed to a patient with extensively drug-resistant tuberculosis (TB). A press briefing is scheduled for today at 2 p.m. ET to provide updates on the situation.